April 27, 2021
PAR-20-077 - National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)
National Cancer Institute (NCI)
The purpose of this Notice is to inform potential applicants about the National Cancer Institute (NCI)’s special interest in providing resources to support highly collaborative, multi-disciplinary Program Projects (P01s) that focus on the development and conduct of cancer control research in low-income and/or underserved populations living in persistent poverty (PP) areas. NCI is interested in programs that address the challenges and opportunities related to working in partnership with local clinics and other health or public health-related organizations to enhance the prevention of cancer and delivery of cancer care strategies to reduce the burden of cancer in PP areas.
There are several areas where NCI can play a significant role in advancing cancer control research in PP areas and improve efforts to achieving health equity for all. This NOSI is a part of a larger NCI research initiative to inform, test, implement, and strengthen cancer control programs that are sustainable in PP areas across the United States (U.S.).
Populations living in poverty in the U.S. — in particular, those living in PP, face higher rates of cancer morbidity and mortality. The U.S. Department of Agriculture’s Economic Research Service has defined counties as being persistently poor if 20% or more of their populations were living in poverty based on 1980, 1990, and 2000 decennial censuses and the 2007-11 American Community Survey 5-year estimates. For a list of PP counties in the USA, click here. Using this definition, there are 353 PP counties in the U.S., comprising 11.2% of all U.S. counties. The large majority (301 or 85%) of the PP counties are nonmetropolitan, accounting for 15.2% of all nonmetropolitan counties in the U.S. Persistent poverty also demonstrates a strong regional pattern, with nearly 84% of PP counties located in the South, comprising more than 20% of all counties located in the region.
An important dimension of poverty, which is defined as having an income below a federally determined poverty threshold, is its persistence over time. An area that has a high level of poverty this year, but not next year, is likely better off than an area that has a high level of poverty for a longer time period. Hence, individuals residing in PP areas are at an increased risk of cancer due to multilevel factors, including lower educational attainment and health literacy, greater exposure to carcinogenic environments, lack of adequate housing and transportation, food insecurity, and inadequate access to health care, among other challenges. Increased risk of cancer for those living in PP areas are also associated with increased cancer incidence and delayed cancer diagnosis, treatment, and subsequently, lower rates of survival.
Although PP by itself is detrimental to health, cancer-related disparities in PP communities may be further exacerbated by race/ethnicity. For example, Blacks living in rural areas in PP fare worse in terms of cancer outcomes compared to Blacks in urban areas. Understanding the intersectionality of PP and other factors, especially in racial and ethnic subgroups, is important to inform targeted prevention and intervention strategies.
To advance cancer control research, the NCI will support a program of research that addresses cancer-related disparities in populations residing in PP areas of the U.S. Proposed scientific projects should include multilevel interventions that address underlying factors affecting poverty and examine other social determinants of health in one or more areas across the cancer control continuum, including prevention, diagnosis, treatment, survivorship, and end-of-life care research.
Please note, the USDA has a separate designation for “Persistent Child Poverty” counties, which is included in the ERS USDA Excel document linked above. The focus of this NOSI is on the 353 “Persistent Poverty” counties, however, if a project is focused on pediatric or childhood cancer (patients less than 18 years of age), the application may propose working in one of the designated Persistent Child Poverty counties.
This NOSI uses the P01 mechanism, and in addition to the criteria set out by NCI for P01 applications, projects/cores should include but are not limited to:
NCI encourages programs to consider developing research projects that include, when relevant, some of the following research concepts and areas:
Applications with the following attributes will be deemed non-responsive and will not be reviewed:
Application and Submission Information:
This notice applies to due dates on or after September 24, 2021, and subsequent receipt dates through May 8, 2023.
Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice.
First Available Due Date
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)
September 24, 2021
All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions:
Applications nonresponsive to terms of this NOSI will not be considered for the NOSI initiative.
Shobha Srinivasan, Ph.D.
Division of Cancer Control and Population Sciences
National Cancer Institute